The Human Proteome Organization presents five distinguished awards annually at the World Congress. HUPO gratefully acknowledges support of the Industrial Advisory Board, Journal of Proteome Research (ACS Publications), and Elsevier as sponsors of three of the annual awards.
It is with great enthusiasm that we present the 2015 HUPO Award Winners! Please join us in congratulating these outstanding scientists on their accomplishments. The awards were presented at the 14th Human Proteome Organization World Congress (HUPO 2015) in Vancouver, BC.
2015 Award Winners
Distinguished Achievement in Proteomic Sciences Award
Sponsored by the Journal of Proteome Research, this award recognizes a scientist for distinguished scientific achievements in the field of proteomic science.
Amanda Paulovich, Fred Hutchinson Cancer Research Center, Seattle, Washington
Dr. Amanda Paulovich is awarded the HUPO Achievement Award 2015 for her significant impact in advancing the accuracy/precision of clinical proteomic mass spectrometry. She has been in the forefront of developing targeted proteomic assays based on Multiple Reaction Monitoring mass spectrometry technology, which can be multiplexed, standardized, reproduced, and shared across laboratories and instrument platforms.
Discovery in Proteomic Sciences Award
The Discovery Award recognizes a scientist for a single discovery in the field of proteomics.
(Shared by two recipients)
Bernhard Kuster, Technische Universitat Munchen, Germany
Akhilesh Pandey, Institute of Genetic Medicine and Department of Biological Chemistry, Oncology and Pathology, John Hopkins University School of Medicine, Baltimore, USA
Professors Bernhard Kuster and Akhilesh Pandey are jointly awarded the 2015 HUPO Discovery Award for their independent large-scale mass spectrometry-based studies of the human proteome. They investigated a wide range of tissues and cell lines with advanced instruments and made their results, published in Nature in May 2014, publicly available through ProteomeXchange for reanalysis by others throughout the proteomics community. Their data were rapidly incorporated into the ongoing Human Proteome Project of HUPO and stimulated renewed interest in confirmation and validation of protein identifications.
Science and Technology Award
Sponsored by the HUPO Industrial Advisory Board, the Science and Technology Award recognizes an individual or team in private industry who played a key role in commercialization of a proteomics technology, product, or procedure. The emphasis for the award is on making the technology, product, or procedure widely available, which is different from the basic scientific invention.
Leigh Anderson, Selena Larkin, and Morteza Razavi
SISCAPA Assay Technologies, Inc., Washington, DC
Leigh Anderson, Morteza Razavi and Selena Larkin are collectively awarded the HUPO Science and Technology Award 2015 for the development of the SISCAPA (Stable Isotope Standards and Capture by Anti-Peptide Antibodies) technology. The SISCAPA assays enable targeted quantitation of proteins and peptides from complex biological samples. The SISCAPA process involves up-front trypsin digestion of the sample followed by immunocapture enrichment of proteotypic peptides that are surrogates for the proteins of interest. Stable isotope labeled peptides are spiked into each sample for relative quantitation of the target molecules via quantitative mass spectrometry (MS).
Distinguished Service Award
The Distinguished Service Award recognizes an exemplary member of the proteomic research community whose dedicated service has made indispensable contributions to the organization and mission of HUPO.
Catherine Costello, Center for Biomedical Mass Spectrometry, Boston University School of Medicine
Prof. Catherine Costello is awarded the Distinguished HUPO Service Award for her long-term dedication to promote HUPO and HUPO activities.
Translational Proteomics Award
Sponsored by Elsevier, the Translational Proteomics Award recognizes a scientist for distinguished scientific achievements in the field of translational proteomics science.
Jennifer Van Eyk, Cedars Sinai Medical Center, Los Angeles, CA
Dr. Jennifer Van Eyk is awarded the HUPO Translational Proteomics Award 2015 for her substantial contributions in translational medicine applying proteomics technology. She was one of the first to validate the concept that disease-induced modified protein biomarkers can add specificity to disease status and discovered the disease induced modifications of cardiac troponin I that revolutionized our understanding of the complexity of heart disease and improved our ability to diagnosis heart attacks. Based on this information she developed assays for the quantification of disease induced modified forms of cardiac troponin I that revolutionized the diagnosis of heart attacks.